Biolase (BIOL) Given Media Impact Rating of 0.11
Media coverage about Biolase (NASDAQ:BIOL) has trended somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a …